AlphaMaven AlphaMaven

Provectus Algae Closes Series A Extension as Breakthrough Programs Move Toward Commercial Scale

Reported by Business Wire
Nov 17, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Provectus Algae closed a US$4.3 million extension to its Series A financing, bringing total Series A funding to more than US$14 million, with At One Ventures as lead investor.
  • • Queensland Investment Corporation (QIC) joined as a new investor, including through the Queensland Government's A$30 million Sowing the Seeds of Farming Innovation Fund, which QIC manages.
  • • Surf'N'Turf, the company's methane-reducing cattle feed, showed a 67% reduction in methane in expired air across commercial pilots with Mort & Co involving more than 2,700 cattle, with no detectable residue and no withholding period.
  • • Commercialisation is being handled by Proteus Ag, which is scaling Queensland manufacturing to support supply of 250,000 cattle in 2027.
  • • The company is also advancing human nutraceutical and crop-protection programs from the same Precision Photosynthesis and AI-enabled biomanufacturing platform.
Summary
Provectus Algae, a Noosaville, Queensland-based biotechnology company, has closed a US$4.3 million extension to its Series A financing, bringing total Series A funding to more than US$14 million, according to a Business Wire release. The Series A was led by At One Ventures, and the extension brings in Queensland Investment Corporation (QIC) as a new investor, including through the Queensland Government's A$30 million Sowing the Seeds of Farming Innovation Fund, which QIC manages. Existing shareholders also continued their support.

The company's lead commercial program is Surf'N'Turf, a methane-reducing cattle feed now being commercialised through Proteus Ag. Commercial pilots with lot-feeding company Mort & Co, involving more than 2,700 cattle, demonstrated a 67% reduction in methane measured in expired air, with no detectable residue and no withholding period. Proteus Ag is progressing the commercial rollout to Australian cattle producers, and manufacturing capacity in Queensland is being scaled to support supply of 250,000 cattle in 2027.

Provectus is also advancing programs in human nutraceuticals and crop-protection biologics drawn from the same Precision Photosynthesis and AI-enabled discovery and biomanufacturing platform. The extension is intended to accelerate those programs and to fund the manufacturing, commercial and supply capabilities Proteus Ag needs for the next phase of Surf'N'Turf.

Founder and CEO Nusqe Spanton said the company has moved from building its technology platform to converting it into products, customers and revenue. At One Ventures founding and managing partner Tom Chi described Surf'N'Turf as a product ready to scale and said it fits into systems producers already run, which simplifies adoption.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Business Wire Provectus Algae Closes Series A Extension as Breakthrough Programs Move Toward Commercial Scale